Zhejiang Vivotide Biotechnologies Company, Ltd. Founded in 2019, it is located in the South Taihu Lake elite entrepreneurship Park, Huzhou City, Zhejiang Province, with a registered capital of 10 million yuan. The company is mainly engaged in the technical development of new drugs, beauty and health care products and environmental protection materials. Its main products include polypeptide and peptide nucleic acid APIs, artificial cell membrane series skin care products, high-efficiency desulfurization and denitration agents, etc. At present, the company has 3000 square meters of R & D laboratory and various equipment. The backbone of the company's scientific research is composed of several experienced Chinese doctors and enterprise managers who have worked in the pharmaceutical field in the United States for many years. About 40% of the company's existing employees have doctoral or master's degrees; More than 20% of employees have foreign educational background and work experience. In terms of intellectual property rights, our company has applied for 52 invention patents in recent years, including one PCT international patent. At present, the enterprise has authorized 10 invention patents.

Vivotide Biotechnologies Company specializes in customized synthesis services of various products including polymer biomaterials and nucleic acid compounds, research and development of pharmaceutical chemical synthesis process, cro project, cGMP preparation technology and other technical services. It has undertaken many projects, including France Sanofi, Shanghai Ambo, Shanghai pengzan, Shanghai Yixin, Wuxi xinnuowei and many other companies, solved key technical problems in the development and pilot test of nucleic acid products for many customers, and played an important role in promoting the development of the industry.